Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Ambu A/S is a Danish company operating in the medical device industry, primarily involved in the development, manufacturing, and marketing of innovative healthcare solutions. The company's key products include single-use endoscopes, anesthesia devices, and patient monitoring and diagnostic solutions. Ambu was founded in 1937 and is headquartered in Ballerup, Denmark. It is known for its focus on single-use devices, which help reduce the risk of cross-contamination and improve efficiency in hospitals and clinics worldwide. The company's strategic positioning emphasizes innovation in medical technology and a strong commitment to addressing healthcare challenges globally.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Ambu A/SEli Lilly
Last price
€11.69$1,365.47
Currency
EUR
USD
€3.1B$1.2T
46.4144.29
€0.26$30.81
1.390.39
€0.05$6.69
0.46%0.51%
Sector
HealthHealth
Employees
5,20050,000
Ticker
€AMBUB$LLY
Primary listing
XGATNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €AMBUB or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.